Landscape of Continuous Glucose Monitoring (CGM) and Integrated CGM: Accuracy Considerations
DIABETES TECHNOLOGY & THERAPEUTICS (2021)
期刊
DIABETES TECHNOLOGY & THERAPEUTICS
卷 23, 期 -, 页码 S5-S11出版社
MARY ANN LIEBERT, INC
关键词
资金
- Abbott Diabetes Care
作者
我是这篇论文的作者
推荐
CGM accuracy: Contrasting CE marking with the governmental controls of the USA (FDA) and Australia (TGA): A narrative review
John S. Pemberton, Emma G. Wilmot, Katharine Barnard-Kelly, Lalantha Leelarathna, Nick Oliver, Tabitha Randell, Craig E. Taplin, Pratik Choudhary, Peter Adolfsson
DIABETES OBESITY & METABOLISM (2023)
Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes
Satish K. Garg, Mark Kipnes, Kristin Castorino, Timothy S. Bailey, Halis Kaan Akturk, John B. Welsh, Mark P. Christiansen, Andrew K. Balo, Sue A. Brown, Jennifer L. Reid, Stayce E. Beck
DIABETES TECHNOLOGY & THERAPEUTICS (2022)
Role of PI3-Kinase in Angiotensin II-Induced Cardiac Hypertrophy: Class I Versus Class III
Tiecheng Zhong, Zonggui Wang, Sayeman Islam Niloy, Yue Shen, Stephen T. O'Rourke, Chengwen Sun
FRONTIERS IN PHARMACOLOGY (2021)
Heterogeneously Integrated Membrane III-V Compound Semiconductor Devices With Silicon Photonics Platform
Shinji Matsuo, Takuma Aihara, Tatsurou Hiraki, Yoshiho Maeda, Toshiki Kishi, Takuro Fujii, Koji Takeda, Takaaki Kakitsuka
IEEE JOURNAL OF SELECTED TOPICS IN QUANTUM ELECTRONICS (2023)
The use of CGM to identify hypoglycemia and glycemic patterns in congenital hyperinsulinism
Martin Gariepy, Niyoosha Yoosefi, Carolina Silva, Jean-Pierre Chanoine, Fatema S. Abdulhussein
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM (2023)
Condylar Positional Changes in Skeletal Class II and Class III Malocclusions after Bimaxillary Orthognathic Surgery
Victor Ravelo, Gabriela Olate, Marcio de Moraes, Claudio Huentequeo, Roberto Sacco, Sergio Olate
JOURNAL OF PERSONALIZED MEDICINE (2023)
Numerical simulation of gas production behavior of class I, class II and class III hydrate reservoirs for different well locations
Kun Ge, Jiaxing Liu, Jiaqi Wang, Zhen Long, Xinyu Zhang, Haoqi Wei, Wei Yu
JOURNAL OF CLEANER PRODUCTION (2023)
FDA Regulation and Approval of Medical Devices: 1976-2020
Jonathan J. Darrow, Jerry Avorn, Aaron S. Kesselheim
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Viscosity Sensors Based on III-Nitride Optical Devices Integrated With Droplet Sliding Channels
Hongying Yang, Yumeng Luo, Gaofei Lu, Yang Chai, Zhiqin Chu, Kwai Hei Li
IEEE ELECTRON DEVICE LETTERS (2022)
Comparison of Accuracy of Freestyle Libre Pro and Medtronic iPro2 Continuous Glucose Monitoring Systems in Pregnancy
Kiran Kumar Golla, Yashdeep Gupta, Alpesh Goyal, Mani Kalaivani, Garima Kachhawa, Vidushi Kulshrestha, Aparna. K. K. Sharma, Jyoti Meena, Juhi Bharti, Jai. B. B. Sharma, Vatsla Dadhwal, Neena Malhotra, Neerja Bhatla, Nikhil Tandon
DIABETES TECHNOLOGY & THERAPEUTICS (2023)
Accuracy Assessment of the GlucoMen(R) Day CGM System in Individuals with Type 1 Diabetes: A Pilot Study
Daniel A. Hochfellner, Amra Simic, Marlene T. Taucher, Lea S. Sailer, Julia Kopanz, Tina Poettler, Julia K. Mader
BIOSENSORS-BASEL (2022)
The hypoglycaemia error grid: A UK-wide consensus on CGM accuracy assessment in hyperinsulinism
Chris Worth, Mark J. Dunne, Maria Salomon-Estebanez, Simon Harper, Paul W. Nutter, Antonia Dastamani, Senthil Senniappan, Indraneel Banerjee
FRONTIERS IN ENDOCRINOLOGY (2022)
Elastodontic Therapy of Hyperdivergent Class II Patients Using AMCOP® Devices: A Retrospective Study
Alessio Danilo Inchingolo, Sabino Ceci, Assunta Patano, Angelo Michele Inchingolo, Valentina Montenegro, Chiara Di Pede, Giuseppina Malcangi, Grazia Marinelli, Giovanni Coloccia, Mariagrazia Garibaldi, Zamira Kruti, Giulia Palmieri, Nicole De Leonardis, Biagio Rapone, Antonio Mancini, Alexandra Semjonova, Ludovica Nucci, Ioana Roxana Bordea, Antonio Scarano, Felice Lorusso, Elisabetta Ferrara, Marco Farronato, Gianluca Martino Tartaglia, Daniela Di Venere, Filippo Cardarelli, Francesco Inchingolo, Gianna Dipalma
APPLIED SCIENCES-BASEL (2022)
Morphological features of Class I, II and III malocclusions of Saudi adolescents
Khalid H. Zawawi, Fahad F. Alsulaimani, Ayman A. Al-Dharrab, Ahmed R. Afify, Mohammad S. Al-Zahrani, Hosam A. Baeshen
SAUDI JOURNAL OF BIOLOGICAL SCIENCES (2021)
The CGM-GRB Study. II. Outflow-Galaxy Connection at z ∼ 2-6
Pradip Gatkine, Sylvain Veilleux, Daniel Perley, Joseph Durbak, Simone Dichiara, S. Bradley Cenko, Eleonora Troja
ASTROPHYSICAL JOURNAL (2022)
Dasiglucagon, a next-generation ready-to-use glucagon analog, for treatment of severe hypoglycemia in children and adolescents with type 1 diabetes: Results of a phase 3, randomized controlled trial
Tadej Battelino, Ramin Tehranchi, Timothy Bailey, Klemen Dovc, Anita Melgaard, Jenine Yager Stone, Stephanie Woerner, Thekla von Dem Berge, Linda DiMeglio, Thomas Danne
PEDIATRIC DIABETES (2021)
Dasiglucagon, a next-generation glucagon analogue, for treatment of severe hypoglycaemia via an autoinjector device: Results of a phase 3, randomized, double-blind trial
Timothy S. Bailey, Julie Willard, Leslie J. Klaff, Jenine Yager Stone, Anita Melgaard, Ramin Tehranchi
DIABETES OBESITY & METABOLISM (2021)
Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study
Satish K. Garg, David Liljenquist, Bruce Bode, Mark P. Christiansen, Timothy S. Bailey, Ronald L. Brazg, Douglas S. Denham, Anna R. Chang, Halis Akturk, Andrew Dehennis, Katherine S. Tweden, Francine R. Kaufman
DIABETES TECHNOLOGY & THERAPEUTICS (2022)
Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes
Satish K. Garg, Mark Kipnes, Kristin Castorino, Timothy S. Bailey, Halis Kaan Akturk, John B. Welsh, Mark P. Christiansen, Andrew K. Balo, Sue A. Brown, Jennifer L. Reid, Stayce E. Beck
DIABETES TECHNOLOGY & THERAPEUTICS (2022)
A Comparative Study of Dasiglucagon Ready-to-Use Autoinjector and Glucagon Emergency Kit During Rescue from Simulated Severe Hypoglycemia
Naila Celeste Bailey, Jeannett Dimsits, Mette Hammer, David M. Kendall, Timothy S. Bailey
DIABETES TECHNOLOGY & THERAPEUTICS (2022)
Real-world outcomes of addition of insulin glargine 300 U/mL (Gla-300) to glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy in people with type 2 diabetes: The DELIVER-G study
Timothy S. Bailey, Jasvinder Gill, Merwyn S. Jones, Laxmi Shenoy, Charlie Nicholls, Jukka Westerbacka
DIABETES OBESITY & METABOLISM (2022)
Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal Trial
Ron Brazg, Satish K. Garg, Anuj Bhargava, James R. Thrasher, Kashif Latif, Bruce W. Bode, Timothy S. Bailey, Barry S. Horowitz, Arvind Cavale, Yogish C. Kudva, Kevin B. Kaiserman, George Grunberger, John Chip Reed, Sarnath Chattaraj, Gina Zhang, John Shin, Vivian Chen, Scott W. Lee, Toni L. Cordero, Andrew S. Rhinehart, Robert A. Vigersky, Bruce A. Buckingham
DIABETES TECHNOLOGY & THERAPEUTICS (2022)
Accuracy of a Seventh-Generation Continuous Glucose Monitoring System in Children and Adolescents With Type 1 Diabetes
Lori M. Laffel, Timothy S. Bailey, Mark P. Christiansen, Jennifer L. Reid, Stayce E. Beck
JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2023)
Insulin Titration Guidelines for Patients With Type 1 Diabetes: It Is About Time!
John Walsh, Ruth Roberts, Timothy S. Bailey, Lutz Heinemann
JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2023)
Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial
Jeremy Pettus, Schafer C. Boeder, Mark P. Christiansen, Douglas S. Denham, Timothy S. Bailey, Halis K. Akturk, Leslie J. Klaff, Julio Rosenstock, Mickie H. M. Cheng, Bruce W. Bode, Edgar D. Bautista, Ren Xu, Hai Yan, Thai Dung, Satish K. Garg, Samuel Klein
NATURE MEDICINE (2022)
Integrated safety and efficacy analysis of dasiglucagon for the treatment of severe hypoglycaemia in individuals with type 1 diabetes
Simon Heller, Tadej Battelino, Timothy S. Bailey, Thomas R. Pieber, Ulrike Hoevelmann, Leona Plum-Moerschel, Anita E. Melgaard, Ronnie Aronson, Linda A. DiMeglio, Thue Johansen, Thomas Danne
DIABETES OBESITY & METABOLISM (2023)
Progressive Acceleration of Insulin Exposure Over 7 Days of Infusion Set Wear
Jasmin R. Kastner, Timothy S. Bailey, Poul Strange, Leon Shi, Keith A. Oberg, Paul J. Strasma, Jeffrey I. Joseph, Douglas B. Muchmore
DIABETES TECHNOLOGY & THERAPEUTICS (2023)
Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial (vol 28, pg 2092, 2022)
Jeremy Pettus, Schafer C. Boeder, Mark P. Christiansen, Douglas S. Denham, Timothy S. Bailey, Halis K. Akturk, Leslie J. Klaff, Julio Rosenstock, Mickie H. M. Cheng, Bruce W. Bode, Edgar D. Bautista, Ren Xu, Hai Yan, Dung Thai, Satish K. Garg, Samuel Klein
NATURE MEDICINE (2023)
Accuracy of the Third Generation of a 14-Day Continuous Glucose Monitoring System
Shridhara Alva, Ronald Brazg, Kristin Castorino, Mark Kipnes, David R. Liljenquist, Hanqing Liu
DIABETES THERAPY (2023)
Accuracy of a 14-Day Factory-Calibrated Continuous Glucose Monitoring System With Advanced Algorithm in Pediatric and Adult Population With Diabetes
Shridhara Alva, Timothy Bailey, Ronald Brazg, Erwin S. Budiman, Kristin Castorino, Mark P. Christiansen, Gregory Forlenza, Mark Kipnes, David R. Liljenquist, Hanqing Liu
JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2022)